Refractory cancer Clinical Trials
Conditions / Refractory cancer
Delta Trials records 2 clinical trials for Refractory cancer in its publicly accessible dataset. From the full dataset, 2 actively seeking eligible participants and 0 trials have reached completion. This research is conducted across 21 study locations around the world. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, with history tracked across multiple versions.
Trial Status
2
Total Trials
2
Recruiting
0
Completed
0
Other Active
0
Terminated since 2020
21
Study Locations
Browse by location (21 total)
- Seattle, United States 1 trialAll trials in Seattle, United States
- Philadelphia, United States 1 trialAll trials in Philadelphia, United States
- Salisbury, United States 1 trialAll trials in Salisbury, United States
- Hamburg, Germany 1 trialAll trials in Hamburg, Germany
- Winston-Salem, United States 1 trialAll trials in Winston-Salem, United States
- Berlin, Germany 1 trialAll trials in Berlin, Germany
- Houston, United States 1 trialAll trials in Houston, United States
- Chicago, United States 1 trialAll trials in Chicago, United States
- Columbus, United States 1 trialAll trials in Columbus, United States
- Heidelberg, Germany 1 trialAll trials in Heidelberg, Germany
- New York, United States 1 trialAll trials in New York, United States
- Boston, United States 1 trialAll trials in Boston, United States
- Munich, Germany 1 trialAll trials in Munich, Germany
- Dresden, Germany 1 trialAll trials in Dresden, Germany
- Bonn, Germany 1 trialAll trials in Bonn, Germany
- Aurora, United States 1 trialAll trials in Aurora, United States
- Würzburg, Germany 1 trialAll trials in Würzburg, Germany
- Miami, United States 1 trialAll trials in Miami, United States
- Pittsburgh, United States 1 trialAll trials in Pittsburgh, United States
- Mainz, Germany 1 trialAll trials in Mainz, Germany